Practice of Acute and Maintenance Electroconvulsive Therapy in the Psychiatric Clinic of a University Hospital from Turkey: Between 2007 and 2013 by Şengül, Melike Ceyhan Balcı. et al.
57
Original Article
http://dx.doi.org/10.9758/cpn.2016.14.1.57 pISSN 1738-1088 / eISSN 2093-4327
Clinical Psychopharmacology and Neuroscience 2016;14(1):57-63 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology
                      
Received: March 16, 2015 /Revised: June 22, 2015
Accepted: August 6, 2015
Address for correspondence: Ayse Nur Inci Kenar, MD
Department of Psychiatry, School of Medicine, Pamukkale 
University, 20070, Denizli, Turkey
Tel: +90-258-4440728, Fax: +90-258-2131034
E-mail: drinci79@hotmail.com
 This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) 
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Practice of Acute and Maintenance Electroconvulsive Therapy in the Psychiatric 
Clinic of a University Hospital from Turkey: between 2007 and 2013
Melike Ceyhan Balci Sengul, Ayse Nur Inci Kenar, Ezgi Hanci, İbrahim Sendur, Cem Sengul, Hasan Herken
Department of Psychiatry, School of Medicine, Pamukkale University, Denizli, Turkey
Objective: Electroconvulsive therapy (ECT) can be given as the form of acute, continuation or maintenance ECT according 
to the process of administration. We report our 7 years’ observation with acute and maintenance ECT in a university hospital 
in Turkey.
Methods: The medical records of the hospitalized patients treated with acute or maintenance ECT between the years 2007 and 
2013 was retrospectively analyzed. The sociodemographic characteristics, diagnosis, data of ECT and the co-administered psy-
chotropic drugs were recorded. The frequency of ECT was calculated by identifying the total number of the hospitalized patients 
during the study period from the hospital records.
Results: A total number of 1,432 female and 1,141 male patients hospitalized in a period of 7 years, with a total number of 111 
patients treated with ECT. The ratio of ECT was 4%, maintenance/acute ECT 11%. For acute ECT, affective disorders (65.3%) 
and psychotic disorders (21.6%) were among the leading diagnoses. Maintenance ECT, the diagnosis was; 6 affective disorders, 
4 psychotic disorders and 1 obsessive compulsive disorder. There was a significant difference between the patients receiving 
acute and maintenance ECT in terms of age, duration of illness, and number of previous hospitalizations and ECTs.
Conclusion: The percentage of patients treated with acute ECT is lower in our institution than that in many other institutions 
from our country. Acute and maintenance ECT should be considered as an important treatment option particularly for patients 
with long disease duration, a high number of hospitalizations and a history of benefiting from previous ECTs.
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INTRODUCTION
Electroconvulsive therapy (ECT) is an effective and 
safe somatic treatment method that is in use for more than 
70 years in psychiatry in the treatment of severe mental 
disorders through inducing generalized epileptic seizure 
by performing an electrical stimulus to the patients’ cra-
nium, usually through two electrodes. The primary in-
dications for ECT use are various psychiatric and neuro-
logical disorders including psychotic depression, suicide 
risk, treatment-resistant mania, schizophrenia, schizo-
affective disorder, catatonic states due to organic causes, 
delirium and neuroleptic malignant syndrome.1-3) 
Variable results have been reported from different 
countries in regard to the prevalence of ECT use. The rate 
of the ECT use can easily be calculated in some developed 
countries like United States, United Kingdom, and 
Australia, where central databases exist. But unfortu-
nately the developing countries like Turkey don’t have 
central statistical collection of data about the treat-
ments.4,5) Turkish studies on the prevalence of ECT usage 
has been reported between 9-16% in hospitalized 
patients.4,6) If we compare the results, the ones from our 
country are higher than those from United States and also 
European countries as well as some of the Asia- Pacific 
countries.5) The reason why they are contradictory can be 
due to collecting data from multi-centers. Also if we con-
sider the amount of the samples and the regions where they 
were collected they may not represent the whole sample 
rate in general population of Turkey.7) ECT should be per-
formed with anesthesia since 2006 in Turkey. Till then 
ECTs were better documented and number of centers us-
ing ECT as a treatment method were on the rise. Only few 
centers were using maintenance ECT method in Turkey 
and details of this method might help other clinicians 
whom want to use this procedure. Unluckily there are lim-
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ited numbers of studies in the literature on maintenance 
ECT, and also most of them are in the form of case reports 
or review of the case reports.1,8) 
In this article we aimed to present sociodemographic 
and clinical characteristics of patients for acute and main-
tenance ECT, and to compare the differences between pa-
tients treated with acute and maintenance ECT.
METHODS
Study Design 
Study was conducted in Psychiatry Clinic of Pamukkale 
University Hospital in Turkey. Our clinic was a part of 
general hospital with 26 beds. The sociodemographic 
characteristics, diagnoses of patients, number of ECT ses-
sions, the stimulus intensity per session, seizure duration 
per session, symptoms, complications, clinical response 
to ECT, number and length of hospitalizations, and the 
co-administered psychotropic drugs during the study peri-
od were filled out from the patients’ medical records retro-
spectively, from 2007 to 2013. The study was approved by 
the institutional ethics committee (2014-02). All the pa-
tients were diagnosed according to the Diagnostic and 
Statistical Manual of Mental Disorders-fourth edition 
(DSM-IV) criteria. ECT choice was preferred mainly for 
the patients who had no response to pharmacotherapy, and 
for the patients who needed rapid improvement because of 
life-threatening symptoms (such as suicide, catatonia) and 
also for the patients who had previously experienced ECT, 
requested the treatment voluntarily. For treated population 
rate, a person was counted only once, irrespective of the 
number of ECT administrations. The parameters of num-
ber of ECT sessions, stimulus intensity per session and 
seizure duration per session for 11 patients treated with 
maintenance ECT were not included in the analysis. The 
patients receiving maintenance ECT were recorded only 
once and in the year the treatment had begun. The re-
sponse of the patient to ECT was calculated by the daily 
observation notes filled by the physician and nurse as well 
as by the analysis of the scores on Clinical Global 
Impression Scale (CGI) were applied before and after 
hospitalization. 
Electroconvulsive Therapy 
ECT was initiated in our department in 2007 and ECT 
procedures had been performed in the operating room un-
der general anesthesia. All ECTs were performed with an-
esthesia in our clinic and anesthesia processes was con-
ducted by anesthesiologists. Our institution is the only 
medical center having an ECT unit in a city of one million 
inhabitants with also serving the patients referred for ECT 
from other institutions. 
ECT is administered by a team including a psychiatry 
resident and nurse and an anesthesia resident and 
technician. Prior to the application of ECT, all patients or 
families must sign informed consent with an explanation 
of the details of the treatment and the anesthesia, as well as 
the anticipated benefits and risks. Before administration 
of ECT, routine laboratory studies including complete 
blood count, blood chemistry, thyroid function test, B12 
and folate levels, electrocardiography (ECG), poster-
oanterior chest X-ray and electroencephalography (EEG) 
are performed. All the patients who are planned to have 
ECT routinely receive consultation by the physicians 
from internal medicine and anesthesia departments. If 
these departments give the patients approval for ECT, an-
esthetic drug administration are instructed to fast for 12 
hours before the procedure. Psychotropic drugs such as 
benzodiazepines and mood stabilizers, which may alter 
seizure threshold significantly, are terminated 12 hours 
before the application. However, patients are allowed to 
continue the typical and atypical antipsychotic drugs, se-
lective serotonin reuptake inhibitors and serotonin-nor-
epinephrine reuptake inhibitors drugs. Prior to the admin-
istration of ECT, 0.5-1 mg of intravenous atropine is given 
to the patients in order to reduce the salivation and to pre-
vent increases in the heart rate. While pentothal or propo-
fol is being used as anesthetic agent, succinylcholine is 
used for muscle relaxation. Their doses are adjusted by the 
anesthesiologist. Patients are continuously oxygenated 
during the procedure, ECG, heart rate and blood pressure 
is monitored and recorded before and after the procedure 
and the anesthetic agent, complications (if developed) and 
the stimulus intensity and seizure duration are routinely 
recorded on the ECT monitoring form. A brief-pulse 
square-wave ECT device (Thymatron system DGX de-
vice; Somatics, Inc., Lake Bluff, IL, USA) is used in all 
ECT procedures. 
Electrical stimulus intensity is determined by using the 
dose titration method. When the minimum level produc-
ing an acceptable seizure is established, it is increased to 
the upper grade. The EEG output on the instrument is used 
in order to monitor if the seizures occur during the ECT 
procedure and intravenous midazolam is immediately 
given if the seizure lasts more than 120 seconds. 
Bilateral-bitemporal ECT is used in our department and 
the acute ECT is administered thrice a week (on Monday, 
Wednesday and Friday) for a total of 7-12 sessions with 
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Table 1. The diagnosis in electroconvulsive therapy-treated patients
Diagnosis Patient Age (yr) Session
Unipolar major depression 47 (42.3) 46.6±15.2 7.4±2.8
Bipolar depression 9 (8.1) 38.3±10.7 8.7±1.7
Schizophrenia 17 (15.3) 32.2±9.2 7.3±3.7
Bipolar manic episodes 17 (15.3) 31.2±11.4 7.9±1.9
Schizoaffective disorder 7 (6.3) 40.4±6.3 7.57±1.5
Obsessive-compulsive disorder 8 (7.2) 41.4±14.6 7.5±1.8
Catatonia 1 (0.9) 18.0±0.0 8.0±0.0
Others 4 (3.6)
Values are presented as number (%) or mean±standard deviation.
Table 2. Data related to electroconvulsive therapy (ECT) 
Variable Data
Receive ECT previously
No 80 (72.1)
One course 5 (4.5)
Two courses 26 (23.4)
Complaints
No 94 (84.7)
Headache 10 (9)
Myalgia 3 (2.7)
Amnesia 4 (3.6)
Sessions 7.6±2.6 (2-12)
Stimulus intensity (joule) 71.5±14.1 (65-103)
Duration of seizures (sec) 26.1±11.2 (23-45)
Values are presented as number (%) or mean±standard deviation 
(range).
the number of sessions are decreased or increased by the 
clinical response of the patient. In our clinic, continuation 
type of ECT can also be given to the patients after follow-
ing a course of acute ECT for up to 6 months in order to 
prevent the relapse. The maintenance ECT is given fol-
lowing the continuation ECT and used to prevent the 
recurrence. Although there is not a consensus on the fre-
quency of the maintenance therapy, most of the practi-
tioners use flexible and individually scheduled weekly/bi-
weekly/monthly courses.
Statistical Analysis 
In statistical analysis, descriptive analysis of the data 
was performed by using SPSS version 17 software (SPSS, 
Inc., Chicago, IL, USA). Quantitative variables were ex-
pressed as mean±standard deviation and categorical varia-
bles were given as numbers and percentages. Chi-square test 
was used to compare the categorical variables. Continuous 
variables were compared by using Mann Whitney U-test. p
＜0.05 was considered as statistically significant.
RESULTS
There were a total of 1,432 female and 1,141 male pa-
tients hospitalized between 2007 and 2013 (female/male 
ratio 1.25:1). During the study period, a total of 111 pa-
tients (100 acute and 11 maintenance ECTs) were treated 
with ECT (4% of the hospitalized patients). The incidence 
of ECT per year were: 1.78%, 2.04%, 5.2%, 7.9%, 5.2%, 
3.9% and 4.2%, respectively (from 2007 to 2013).
Sociodemographic Characteristics of Patients 
Of the patients 59 (53.2%) were male and 52 (46.8%) 
were female (male/female ratio 1.31:1). Between the years 
2007 and 2013, 3.6% of the female hospitalized patients and 
5.1% of the male hospitalized patients were treated by ECT. 
There was no pregnant woman among the ECT-treated fe-
male patients. The mean age of the patients was 40.3＋
14.2 years (range, 18-78 years). With regard to the marital, 
education, employment status of the ECT-treated patients, 
65 (58.6%) were married, 37 (33.3%) were housewife, 45 
(40.5%) were in primary school. Fifty-eight (52.2%) pa-
tients were no medical co-morbidities. Sixty-two patients 
(55.9%) were referred from outpatient clinic.
Diagnosis of Patients 
With regard to the diagnostic distribution of the pa-
tients, 47 (42.3%) had unipolar major depression, the 
mean age was 46.6±15.1 years and the number of mean 
session was 7.4±2.8 for depressive patients. The other di-
agnostic groups, the mean age and the number of session 
in ECT-treated patients were given in Table 1.
Data Related to ECT 
Of the ECT-treated patients, 80 (72.1%) did not receive 
ECT previously, while 5 (4.5%) had one and 26 (23.4%) 
had two courses of ECT previously. The mean disease du-
ration for all patients treated with ECT was 117.8±104.4 
months (range, 1-528 months), the mean number of hospi-
talizations was 3.3±2.8 (range, 1-14), the mean number of 
ECT sessions was 7.6±2.6 (range, 2-18).
With regard to the mean number of sessions until the re-
sponse to treatment, 84.0% of the patients responded in 
session 7 or later, 37.0% responded within the first 3 ses-
sions and 2.8% responded in session 3-6, while 9.3% had 
an inadequate response. 
The mean length of hospitalization was 27.4±12.4 days 
(range, 7-82 days). The most common complaint was 
headache in 10 (9.0%), myalgia in 3 (2.7%) and amnesia 
in 4 (3.6%) patients. The rate of complications was found 
to be 0.3% with being anterograde amnesia in 1, prolonged 
seizure in 3, apnea in 1, and arrhythmia in 1 patient. 
For all sessions, mean stimulus intensity was 71.5±14.1 
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Table 3. The psychotropic drugs used in addition to electrocon-
vulsive therapy
Drug Number (%)
One psychotropic drug 33 (29.7)
Two psychotropic drugs 46 (41.4)
Three or more psychotropic drugs 32 (28.8)
Antidepressants
Venlafaxine 27 (24.3)
Mirtazapine 7 (6.3)
Milnacipran 5 (4.5)
Fluoxetine 5 (4.5)
Paroxetine 5 (4.5)
Sertraline 4 (3.6)
Bupropione 4 (3.6)
Duloxetine 4 (3.6)
Clomipramine 4 (3.6)
Fluvoxamine 2 (1.8)
Antipsychotics
Quetiapine 49 (44.1)
Olanzapine 35 (31.5)
Aripirazole 18 (16.2)
Risperidone 11 (9.9)
Amilsulpride 10 (9.0)
Paliperidone 7 (6.3)
Flupentixol 4 (3.6)
Zuklopentixol 2 (1.8)
Clozapine 1 (0.9)
Haloperidol 1 (0.9)
Clorpromazine 1 (0.9)
Table 4. Comparison of patients treated with acute and mainte-
nance electroconvulsive therapy (ECT) 
Variable
Maintenance 
ECT 
Acute 
ECT
p value*
Patient (n) 11 100
Age (yr) 53.9±9.5 38.8±13.9 0.01†
Number of hospitalizations 3.1±2.5 5.0±4.1 0.37
Receive ECT previously 0.6±1.2 2.4±1.2 0.00†
Duration of illness (mo) 101.9±96.1 201.5±114.9 0.02†
Values are presented as number only or mean±standard deviation.
*Mann Whitney U test was performed. †p＜0.05.
joules and mean duration of the seizures was 26.1+11.2 
seconds (Table 2).
Psychotropic Drugs Used with ECT 
Of the patients, 33 (29.7%) were using one, 46 (41.4%) 
were using two and 32 (28.8%) were using three or more 
psychotropic drugs in addition to ECT. Of the patients un-
der antidepressant drug therapy, 27 (24.3%) were using 
venlafaxine, under antipsychotic drug therapy, 49 (44.4%) 
were using quetiapine. One other catatonic patient was us-
ing benzodiazepine (Table 3).
Maintenance ECT 
A total of 11 patients received maintenance ECT, for 
which the mean duration of maintenance ECT was 13.8 
months (range, 8-46 months). Of these 11 patients, 2 were 
still on the maintenance ECT at time of writing of this 
paper. The diagnosis was unipolar depression in 4, bipolar 
depression in 1, schizophrenia in 2, obsessive-compulsive 
disorder (OCD) in 1, bipolar manic episodes in 1 and 
schizoaffective disorder in 2 of 11 patients receiving 
maintenance ECT. 
There was a significant difference between the patients 
receiving maintenance and acute ECT in terms of age, du-
ration of illness, and number of previous hospitalizations 
and ECTs. The mean age was 53.9±9.5 vs. 38.8±13.9 
years, the mean duration of illness was 101.9±96.1 vs. 
201.5±114.9 months, the mean number of previous hospi-
talizations was 3.1±2.5 vs. 5.0±4.1 and number of pre-
vious ECTs was 0.6±1.2 vs. 2.4±1.2 in patients treated 
with acute and maintenance ECT, respectively (p＜0.01) 
(Table 4). 
DISCUSSION
In the present study, the ECT rate among the inpatients 
of our psychiatry clinic during the survey period was 4%. 
Previous retrospective naturalistic studies in Turkey re-
ported rates ranging from 2.2% and 16.4%.4) Our results 
show that the rate of ECT usage is higher than the rates in 
the Western countries, but it is lower than the certain 
Africa and Asia countries.5,9) However, this ratio does not 
show the prevalence of ECT use in the general psychiatric 
population in Turkey. All the results of data collected from 
Turkey are higher than the rate we found in the present 
study. The literature suggests there is a wide variation in 
choosing ECT practice in countries and even between the 
regions within a country. These differences may be attrib-
uted to the differences in prejudices and legislations about 
ECT, technical staff and equipment, available number of 
hospital beds, the site of providing service, the institutions 
the studies had been conducted and the time periods 
studied. The rate of ECT use might be underestimated in 
the present study due to the facts that it covers a long study 
period of 7 years, there is no closed psychiatric clinic in 
the institution, low number of beds, it has been conducted 
in a smaller city and the healthcare providers in this in-
stitution may have different approaches to ECT. 
According to the results of present study, ECT is most 
commonly used in patients with major depression, fol-
lowed by those with schizophrenia and manic episode. In 
the 15-year study of Saatcioglu and Tomruk,4) the most 
common indication for ECT was bipolar depression, fol-
lowed by schizophrenia and major depression in Turkey. 
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On the other hand, the most common indication for ECT 
were schizophrenia in an Hungarian and Asian study, af-
fective disorders (unipolar or bipolar depression) in pa-
tients from US, Australia, New Zealand and Europe.5,9-11) 
The present study had a total of 11 patients treated with 
maintenance ECT. Of these 11 patients, the diagnosis was 
unipolar depression in 4, bipolar depression in 1, bipolar 
manic episode in 1, schizophrenia in 2, schizoaffective 
disorder in 2 and OCD in 1 patient. Thus, more than half of 
the maintenance ECT-treated patients had an affective 
disorder. Accordingly, there are some previous studies re-
porting the higher use and effectiveness of maintenance 
ECT in affective disorders, especially the depression.1,12,13) 
There are only anecdotal reports of individual with main-
tenance ECT in pharmacotherapy refractory OCD (co-
morbid schizoaffective disorder or bipolar disorder).14,15) 
Our case was not comorbid any psychiatric disorder, he 
was pharmacotherapy refractory OCD, showing a reduc-
tion of OCD symptoms with 18 months of maintenance 
ECT. Although the primary diagnosis for ECT is major 
depression in some studies and psychotic disorders in oth-
ers, ECT is considered as an important treatment option 
for the relief of symptoms in patients with major depres-
sion, bipolar disorder and psychotic disorders.
Although maintenance ECT is less used compared to 
the acute ECT, recent studies have provided more in-
formation about maintenance ECT. However, there is no 
consensus on the frequency of ECT sessions.1,8) Although 
it can be individualized, maintenance ECT is usually giv-
en weekly in the first 4-6 months, biweekly for the sub-
sequent 4-6 months and monthly thereafter in our depart-
ment. Maintenance ECT lasted for a mean duration of 13.8 
months (range, 8-46 months). Of these 11 patients, 2 were 
still continued to receive maintenance ECT at the time of 
writing this paper. Controversy also exists on the duration 
of maintenance ECT. It is usually determined individually 
according to the side effects and the response to treatment. 
A comprehensive review have reported that the time peri-
ods for the duration of ECT varied up to 7 years and that 
vast majority of cases used co-medications.1) Accordingly, 
all maintenance ECT-treated patients were receiving psy-
chotropic drugs in the present study. 
The patients treated with maintenance ECT were older 
and had longer disease duration, a higher number of hospi-
talizations and a higher number of previous ECTs com-
pared to those treated with acute ECT. It should be kept in 
mind that continuation and maintenance ECT are effec-
tive treatment options particularly in patients who had 
benefited previously from the acute ECT.
The mean number of ECT sessions was 7.57±2.59 for 
all acute ECTs. There was no difference between the diag-
nostic groups in terms of the number of sessions. 
Although it can be individualized, ECT is usually given 
for 6-12 sessions.6,16,17) The mean duration of hospital-
ization was 27.43±12.43 days, with no significant differ-
ence between the diagnostic groups. This is similar to that 
of Balikci et al.6) and is lower than that of Canbek et al.,16) 
which may be related with the rapid process of deci-
sion-making and preparation for ECT in our institution. 
The mean duration of seizures was 26.14±11.23 sec-
onds for all sessions. An adequate seizure should last at 
least in 25 seconds. Although the duration of seizures is an 
inadequate parameter for assessing the effectiveness of 
ECT, convulsions lasting less than 15 seconds and seizure 
activity on EEG lasting less than 25 seconds are consid-
ered to indicate the ineffectiveness of ECT.2,6,16)
The mean stimulus intensity was 71.53±14.12 joules. It 
is well known that electrical stimulus parameters are im-
portant in terms of effectiveness and side effects of ECT. 
It should be used at the lowest dose possible to achieve re-
sponse to treatment.18,19) 
Similar to the previous studies, most patients in our 
study showed a clinical improvement and remission or a 
complete remission according to DSM-IV criteria for the 
severity and the course modifiers.4,5) Remission was also 
defined as the state in which patients can lead a somewhat 
social life. Of the patients, 84% responded to the treatment 
at session 7 or later, thus it was concluded that the patient 
should not be considered as unresponsive unless 8 ses-
sions have been completed. Some previous have reported 
an earlier response to the therapy.16) However, it is a major 
limitation of the present study that evaluation of the re-
sponse to the therapy was based on CGI (CGI is a global 
index and not specific rating scale for diagnosis) and ob-
servation notes of the physicians and nurses. 
The most common side effect was headache, memory 
problems and muscle pain. In particular, previous studies 
have commonly reported subjective memory impairment 
and pain in ECT-treated patients.4,5) Although nearly half 
of the patients had co-morbidities including diabetes mel-
litus, hypertension and thyroid diseases, the rate of com-
plications was only 0.3% in the present study, with being 
anterograde amnesia in 1, prolonged seizure in 3, apnea in 
1 and arrhythmia in 1 patient. There was no serious com-
plication necessitating the termination of ECT. It is possi-
ble that because all ECT procedures are modified and all 
patients are examined in detail before the procedure, risk 
of complication has reduced.
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Of the patients, 33 (29.7%) were using one, 46 (41.4%) 
were using two and 32 (28.8%) were using three or more 
psychotropic drugs in addition to ECT, with the number of 
drugs used is being not correlated with the duration of 
seizures. To our knowledge, there are no previous studies 
on the relationship between the co-medications and ECT. 
Most commonly used drugs were venlafaxine (24.3%) 
among the antidepressant drugs and quetiapine (44.1%), 
followed by olanzapine (31.5%) and aripiprazole (16.2%) 
among the antipsychotic drugs. Although there are some 
previous case reports on the development of bradycardia 
and asystole with ECT use in patients receiving venlafaxine, 
some authors have suggested that the drug can be safely 
used with ECT.12,13,20,21) However, only one of our cases 
used venlafaxine has developed arrhythmia. There are a 
few studies on the simultaneous use of antipsychotic 
drugs with ECT, with most of them are being in the form of 
case reports and patient series or open follow-up studies.22-24) 
The present study found no relationship between drug use 
and seizure duration or rate of complications.
According to the results of the present study, main-
tenance ECT should be considered particularly in patients 
with a longer duration of hospitalization, with a high num-
ber of hospitalization and who had benefited previously 
from ECT. However, it is the major limitations of the pres-
ent study that it is a retrospective study of medical records, 
our findings might not be generalized to Turkey and that 
there was a great number of acute ECT and limited num-
ber maintenance ECT groups. Moreover, adequate clin-
ical data was not available and any scale except for CGI 
was not used for the specific assessment of diagnosis treat-
ment response. Nevertheless, present study has some ad-
vantages including covering a long period of evaluation of 
7 years (between the years 2007 and 2013), involving the 
patients treated with maintenance ECT, including a stand-
ard form (ECT monitoring form) consisting of the diag-
nosis, stimulus intensity, seizure duration, symptoms and 
complications, evaluating the concomitant use of psycho-
tropic drugs and response the treatment. The results of the 
present study may be used to communicate about the im-
portance of more standard and thoughtful ECT monitor-
ing forms across the entire country for a better data collec-
tion and for an improved oversight. Reconsideration of the 
ECT procedures by the institutions may contribute to the 
systematic education of the psychiatry residents on ECT. 
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